Risk of adverse events after Omicron XBB-adapted BNT162b2 COVID-19 vaccination in the United States
2019-20 coronavirus outbreak
Betacoronavirus
Pandemic
Coronavirus Infections
DOI:
10.1016/j.vaccine.2024.126629
Publication Date:
2024-12-18T20:14:46Z
AUTHORS (10)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....